Authors: Goodkin, DA Mapes, DL Held, PJ

Citation: Da. Goodkin et al., The dialysis outcomes and practice patterns study (DOPPS): How can we improve the care of hemodialysis patients?, SEMIN DIAL, 14(3), 2001, pp. 157-159

Authors: Goodman, WG Frazao, JM Goodkin, DA Turner, SA Liu, W Coburn, JW

Citation: Wg. Goodman et al., A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism, KIDNEY INT, 58(1), 2000, pp. 436-445

Authors: Young, EW Goodkin, DA Mapes, DL Port, FK Keen, ML Chen, K Maroni, BL Wolfe, RA Held, PJ

Citation: Ew. Young et al., The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study, KIDNEY INT, 57, 2000, pp. S74-S81

Authors: Besarab, A Bolton, WK Nissenson, AR Schwab, SJ Goodkin, DA

Citation: A. Besarab et al., The Normal Haematocrit Trial in dialysis patients with cardiac disease, NEPH DIAL T, 14(8), 1999, pp. 2043-2044

Authors: Goodkin, DA Gimenez, LF Graber, SE Van Stone, JC Egrie, JC Okamoto, DM

Citation: Da. Goodkin et al., Hematocrit stability following intravenous versus subcutaneous administration of epoetin alfa to dialysis patients: a post hoc analysis, CLIN NEPHR, 51(6), 1999, pp. 367-372

Authors: Nissenson, AR Schwab, SJ Goodkin, DA

Citation: Ar. Nissenson et al., Effects of normal as compared with low hematocrit values in patients with cardiac disease undergoing hemodialysis and receiving epoetin - Reply, N ENG J MED, 339(27), 1998, pp. 2023-2024